AN UNBIASED VIEW OF LINK ALTERNATIF MBL77

Not all people with CLL need therapy. Irrespective of all recent improvements, the iwCLL nonetheless endorses watchful observation for individuals with asymptomatic sickness.86 This recommendation relies on not less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FC